Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants

NCT01030575 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.

NCT NCT01030575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01030575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Lead sponsor
NICHD Neonatal Research Network
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2010
Completion date
September 30, 2013
Enrollment
125 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia (bpd), infant, low birth weight, infant, newborn, infant, premature, infant, small for gestational age, retinopathy of prematurity